A Study of the Safety and Efficacy of Injectable Thymosin Beta 4 for Treating Acute Myocardial Infarction
Clinical trial NCT01311518 · WITHDRAWN
Trial details
- NCT number
- NCT01311518
- Sponsor
- RegeneRx Biopharmaceuticals, Inc.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-01
- Primary completion
- 2020-07-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.